RT Book, Section A1 Bar-Yosef, Shahar A1 Schroeder, Rebecca A. A1 Mark, Jonathan B. A2 Longnecker, David E. A2 Brown, David L. A2 Newman, Mark F. A2 Zapol, Warren M. SR Print(0) ID 56630059 T1 Chapter 30. Hemodynamic Monitoring T2 Anesthesiology, 2e YR 2012 FD 2012 PB The McGraw-Hill Companies PP New York, NY SN 978-0-07-178513-6 LK accessanesthesiology.mhmedical.com/content.aspx?aid=56630059 RD 2024/04/20 AB When interpreting invasive hemodynamic pressures, consideration should be given to technical aspects including the zero reference level, dynamic response of the monitoring system, and effects of changes in intrathoracic pressures.Much diagnostic information can be gleaned from the analog waveform of directly measured pressures, both arterial blood pressure and cardiac filling pressures.Interpretation of filling pressures like central venous pressure (CVP) and pulmonary artery occlusion pressure (PAOP) is confounded by many variables, notably changes in ventricular compliance, valvular abnormalities, and positive pressure ventilation.Pulmonary artery catheter monitoring without a structured therapeutic intervention protocol has generally not been found to be beneficial in most perioperative and critical care settings. It might still be justified in very high-risk patients or in critically ill patients who do not respond to empiric therapy.There are no accepted gold standards for cardiac output measurement. It is more clinically useful to follow trends in cardiac output rather than considering absolute values.Functional indices based on respiratory variation in hemodynamic parameters are better predictors of fluid responsiveness compared with static filling pressures or volumetric indices.Metabolic indices like lactate, base excess, and venous oxygen saturation should be included in the hemodynamic assessment of the critically ill patient.Preemptive goal directed therapy, aimed at optimization of hemodynamic goals before and during surgery, has been found to decrease mortality in high-risk surgical patients and decrease morbidity in moderate-risk patients.